AO: The analyst provides detailed accounting of the history of the HPV vaccine and highlights the need for such understands in order to better understand more concretely the possibilities for “ethical action” as they inhere in lived historical events. In other words, the analyst calls for “situated ethics” that account for the economic and legal infrastructures that shape what is or isn’t possible. She is pushing back against the idea that pharmaceutical R&D scientists are only motivated by profit. However, her argument would be strengthened by greater ethnographic detail about what it is that exactly drives scientists to do what they do, i.e. the nano and deutero level of analysis. Her analysis largely focuses on the macro.